Polaris Venture Management Co. V »

X4 Pharmaceuticals shares owned by Polaris Venture Management Co. V

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Polaris Venture Management Co. V from 13F filings

Historical chart of Polaris Venture Management Co. V investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Polaris Venture Management Co. V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Polaris Venture Management Co. V

Quarter filed Position value Share count Share price at filing
2021-09-30 $1.6M 312k 5.29
2021-06-30 $2.0M 312k 6.50
2021-03-31 $2.7M 312k 8.61
2020-12-31 $2.0M 312k 6.43
2020-09-30 $2.1M 312k 6.77
2020-06-30 $2.9M 312k 9.32
2020-03-31 $3.1M 312k 10.00
2019-12-31 $3.3M 312k 10.70
2019-09-30 $4.0M 312k 12.71
2019-06-30 $4.7M 312k 15.00
2019-03-31 $5.4M 312k 17.41

More positions owned by Polaris Venture Management Co. V

Lyra Therapeutics Common Stock (LYRA)
x4 Pharmaceuticals Common Stock (XFOR)
Atyr Pharma Common Stock
Dare Bioscience Common Stock (DARE)
Genocea Biosciences Common Stock (GNCAQ)
Pulmatrix Common Stock

View all positions for Polaris Venture Management Co. V

Top funds holding X4 Pharmaceuticals

NEA Management Company
Vanguard Group
OrbiMed Advisors
Perceptive Advisors
Kingdon Capital Management
Citadel Advisors
Millennium Management
GSA Capital Partners
Point72 Asset Management
Schonfeld Strategic Advisors
Propel Bio Management
Barclays
Simplify Asset Management
Royce & Associates
Bank of New York Mellon

View all funds holding X4 Pharmaceuticals